1141 related articles for article (PubMed ID: 15028346)
1. Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation.
Rockson SG; Albers GW
J Am Coll Cardiol; 2004 Mar; 43(6):929-35. PubMed ID: 15028346
[TBL] [Abstract][Full Text] [Related]
2. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
[TBL] [Abstract][Full Text] [Related]
3. [New international guidelines on antithrombotic therapy in atrial fibrillation].
Tveit A
Tidsskr Nor Laegeforen; 2009 Jun; 129(13):1332-5. PubMed ID: 19561659
[TBL] [Abstract][Full Text] [Related]
4. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
Lin LJ; Cheng MH; Lee CH; Wung DC; Cheng CL; Kao Yang YH
Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379
[TBL] [Abstract][Full Text] [Related]
5. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
[TBL] [Abstract][Full Text] [Related]
6. [Atrial fibrillation and thromboembolic events prevention. State of the art].
Matteoli S; Trappolini M; Chillotti FM
Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
[TBL] [Abstract][Full Text] [Related]
7. Newly detected atrial fibrillation and compliance with antithrombotic guidelines.
Glazer NL; Dublin S; Smith NL; French B; Jackson LA; Hrachovec JB; Siscovick DS; Psaty BM; Heckbert SR
Arch Intern Med; 2007 Feb; 167(3):246-52. PubMed ID: 17296879
[TBL] [Abstract][Full Text] [Related]
8. Warfarin and aspirin use in atrial fibrillation among practicing cardiologist (from the AFFECTS Registry).
Kowey PR; Reiffel JA; Myerburg R; Naccarelli GV; Packer DL; Pratt CM; Reiter MJ; Waldo AL;
Am J Cardiol; 2010 Apr; 105(8):1130-4. PubMed ID: 20381665
[TBL] [Abstract][Full Text] [Related]
9. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
[TBL] [Abstract][Full Text] [Related]
10. A cautionary note on data sources for evidence-based clinical decisions: warfarin and stroke prevention.
Thomson R; Eccles M; Wood R; Chinn DJ
Med Decis Making; 2007; 27(4):438-47. PubMed ID: 17641140
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
DiMarco JP; Flaker G; Waldo AL; Corley SD; Greene HL; Safford RE; Rosenfeld LE; Mitrani G; Nemeth M;
Am Heart J; 2005 Apr; 149(4):650-6. PubMed ID: 15990748
[TBL] [Abstract][Full Text] [Related]
12. Are atrial fibrillation patients receiving warfarin in accordance with stroke risk?
Zimetbaum PJ; Thosani A; Yu HT; Xiong Y; Lin J; Kothawala P; Emons M
Am J Med; 2010 May; 123(5):446-53. PubMed ID: 20399322
[TBL] [Abstract][Full Text] [Related]
13. Stroke risk in atrial fibrillation patients on warfarin. Predictive ability of risk stratification schemes for primary and secondary prevention.
Poli D; Antonucci E; Grifoni E; Abbate R; Gensini GF; Prisco D
Thromb Haemost; 2009 Feb; 101(2):367-72. PubMed ID: 19190823
[TBL] [Abstract][Full Text] [Related]
14. Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study.
Sherman DG; Kim SG; Boop BS; Corley SD; Dimarco JP; Hart RG; Haywood LJ; Hoyte K; Kaufman ES; Kim MH; Nasco E; Waldo AL;
Arch Intern Med; 2005 May; 165(10):1185-91. PubMed ID: 15911734
[TBL] [Abstract][Full Text] [Related]
15. Confronting atrial fibrillation in the elderly: stroke risk stratification and emerging antithrombotic therapies.
Strong SH; Halperin JL
Geriatrics; 2007 Mar; 62(3):22-7. PubMed ID: 17346095
[TBL] [Abstract][Full Text] [Related]
16. Anticoagulation and atrial fibrillation.
Atwood JE; Albers GW
Herz; 1993 Feb; 18(1):27-38. PubMed ID: 8454250
[TBL] [Abstract][Full Text] [Related]
17. Doctors' beliefs on the use of antithrombotic therapy in atrial fibrillation: identifying barriers to stroke prevention.
Peterson GM; Boom K; Jackson SL; Vial JH
Intern Med J; 2002; 32(1-2):15-23. PubMed ID: 11783668
[TBL] [Abstract][Full Text] [Related]
18. Atrial fibrillation and stroke. Three new studies, three remaining questions.
Albers GW
Arch Intern Med; 1994 Jul; 154(13):1443-8. PubMed ID: 8017999
[TBL] [Abstract][Full Text] [Related]
19. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Singer DE; Albers GW; Dalen JE; Fang MC; Go AS; Halperin JL; Lip GYH; Manning WJ
Chest; 2008 Jun; 133(6 Suppl):546S-592S. PubMed ID: 18574273
[TBL] [Abstract][Full Text] [Related]
20. Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls.
Garwood CL; Corbett TL
Ann Pharmacother; 2008 Apr; 42(4):523-32. PubMed ID: 18334606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
